Ken W. Marshall, Commercial Leader at Aquestive Therapeutics, Inc. (AQST), bought 1,445 shares at $10.15 ($15K) on 2018-11-21, disclosed to the SEC on 2018-12-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.